Business briefs: pharma websites among top ten

Share this article:

Pharmas may be generally hypercautious and/or inept at online communications, but the 2013 Financial Times Bowen Craggs Index of corporate web effectiveness ranks several among its Top Ten. Roche came in at No. 7, followed by Novartis and GSK (a little further down the list, AstraZeneca placed 14th, Novo Nordisk 16th and Sanofi 21st). The firm pointed to Roche's “visually beautiful site” and said the company “is not afraid to use ‘authentic' photography to illustrate its stories,” and said Novartis had “polished its site over several years to tackle reputation issues well,” while hailing GSK as “one of this year's big improvers” with “notable integration of social media channels.”

Congress continues to eye DTC advertising tax deductability as a possible cost-savings target. In a recent Senate Finance Committee white paper, DTC deductability was cited as one potential avenue of tax reform, along with deductability of advertising for foods aimed at children. DTC tax deductability was the topic of a major behind-the-scenes lobbying battle as the Affordable Care Act was being hashed out three years ago. The mention, said the Coalition for Healthcare Communication, is “not yet a cause for alarm,” but “demonstrates yet again that no bad idea disappears quickly in DC and that careful listening and speaking is often needed.”

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.